This is the authors' abstract. We don't add key points for this paper.
Studies have consistently shown a substantially increased mortality in SSc, predominantly due to cardio-pulmonary complications. A better understanding of risk factors for mortality holds the promise of improving outcomes in this devastating multiorgan autoimmune disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Nikpour et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: